Metraipolis › archive › dc_cfd98ffd6baa

Disease characteristics and serological responses in patients with differing severity of COVID-19 infection: A longitudinal cohort study in Dhaka, Bangladesh — Europe PMC PMID:34982773

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/34982773
DOI
10.1371/journal.pntd.0010102
License (as archived)
CC0-1.0
Archived
2026-10-31T17:18:05.467Z
SHA-256 of the archived text
b16a79bd24889b8abf035b7de7de2db310d24a42d2e5af8613d26ac6cd75e824
Stable URL of this page
https://metraipolis.com/documento/dc_cfd98ffd6baa

How to cite

Disease characteristics and serological responses in patients with differing severity of COVID-19 infection: A longitudinal cohort study in Dhaka, Bangladesh — Europe PMC PMID:34982773 — Europe PMC (en), https://europepmc.org/article/MED/34982773 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_cfd98ffd6baa (Metraipolis archive dc_cfd98ffd6baa, sha256 b16a79bd24889b8abf035b7de7de2db310d24a42d2e5af8613d26ac6cd75e824)
BibTeX
@misc{dccfd98ffd6baa,
  title = {Disease characteristics and serological responses in patients with differing severity of COVID-19 infection: A longitudinal cohort study in Dhaka, Bangladesh — Europe PMC PMID:34982773},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/34982773},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_cfd98ffd6baa; sha256 b16a79bd24889b8abf035b7de7de2db310d24a42d2e5af8613d26ac6cd75e824},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/34982773. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Background: COVID-19 caused by SARS-CoV-2 ranges from asymptomatic to severe disease and can cause fatal and devastating outcome in many cases. In this study, we have compared the clinical, biochemical and immunological parameters across the different disease spectrum of COVID-19 in Bangladeshi patients. Methodology/principal findings: This longitudinal study was conducted in two COVID-19 hospitals and also around the community in Dhaka city in Bangladesh between November 2020 to March 2021. A total of 100 patients with COVID-19 infection were enrolled and classified into asymptomatic, mild, moderate and severe cases (n = 25/group). In addition, thirty age and sex matched healthy participants were enrolled and 21 were analyzed as controls based on exclusion criteria. After enrollment (study day1), follow-up visits were conducted on day 7, 14 and 28 for the cases. Older age, male gender and co-morbid conditions were the risk factors for severe COVID-19 disease. Those with moderate and severe cases of infection had low lymphocyte counts, high neutrophil counts along with a higher neutrophil-lymphocyte ratio (NLR) at enrollment; this decreased to normal range within 42 days after the onset of symptom. At enrollment, D-dimer, CRP and ferritin levels were elevated among moderate and severe cases. The mild, moderate, and severe cases were seropositive for IgG antibody by day 14 after enrollment. Moderate and severe cases showed significantly higher IgM and IgG levels of antibodies to SARS-CoV-2 compared to mild and asymptomatic cases. Conclusion/significance: We report on the clinical, biochemical, and hematological parameters associated with the different severity of COVID-19 infection. We also show different profile of antibody response against SARS-CoV-2 in relation to disease severity, especially in those with moderate and severe disease manifestations compared to the mild and asymptomatic infection.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PLoS neglected tropical diseases, 2022 (prima pubblicazione 2022-01-04).
Identificativi: PMID 34982773 · PMCID PMC8759637 · DOI 10.1371/journal.pntd.0010102.
Descrittori MeSH principali: Severity of Illness Index.
Pagina: https://europepmc.org/article/MED/34982773 — https://doi.org/10.1371/journal.pntd.0010102. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-31T17:09:33.898Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.